Drug ID: | NPD4997 |
Drug Name: | |
Molecular Formula: | C22H23N3O4S |
Canonical SMILES: | COc1cc(ccc1OC)C(=O)N1CCCc2c1ccc(c2)C1=NN=C(SC1C)O |
Standard InCHI: | InChI=1S/C22H23N3O4S/c1-13-20(23-24-22(27)30-13)15-6-8-17-14(11-15)5-4-10-25(17)21(26)16-7-9-18(28-2)19(12-16)29-3/h6-9,11-13H,4-5,10H2,1-3H3,(H,24,27) |
Standard InCHIKey: | IZLRMTJLQCLMKF-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB005317 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 425.14 |
ALogP | -0.1364 |
MLogP | 3 |
XLogP | 4.332 |
HDA | 5 |
HBD | 1 |
Rotatable Bonds | 9 |
TPSA | 109.02 |
RO5 Violation | 0 |